| 000 | 00936 a2200277 4500 | ||
|---|---|---|---|
| 005 | 20250510211016.0 | ||
| 264 | 0 | _c19780828 | |
| 008 | 197808s 0 0 eng d | ||
| 022 | _a0140-6736 | ||
| 024 | 7 |
_a10.1016/s0140-6736(78)91409-5 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aChouinard, G | |
| 245 | 0 | 0 |
_aSchizophrenia as dopamine-deficiency disease. _h[electronic resource] |
| 260 |
_bLancet (London, England) _cJul 1978 |
||
| 300 |
_a99-100 p. _bdigital |
||
| 500 | _aPublication Type: Letter | ||
| 650 | 0 | 4 |
_aCorpus Striatum _xpathology |
| 650 | 0 | 4 |
_aDopamine _xdeficiency |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aNeurons _xphysiology |
| 650 | 0 | 4 |
_aReceptors, Dopamine _xphysiology |
| 650 | 0 | 4 |
_aSchizophrenia _xdrug therapy |
| 700 | 1 | _aJones, B D | |
| 773 | 0 |
_tLancet (London, England) _gvol. 2 _gno. 8080 _gp. 99-100 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0140-6736(78)91409-5 _zAvailable from publisher's website |
| 999 |
_c76397 _d76397 |
||